[1]
J. Pinthus, “Follicle stimulating hormone (FSH): A potential surrogate marker for androgen deprivation therapy (ADT) oncological and systemic effects”., CUAJ, vol. 9, no. 3-4, pp. E226–7, Apr. 2015.